Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;61(4):160-2.
doi: 10.4103/0301-4738.111063.

Relation between platelet indices and branch retinal vein occlusion in hypertensive patients

Halil Ibrahim Onder  1 , Ali Cagri Kilic, Murat Kaya, Serkan Bulur, Elif Onder, Murat Tunc
Affiliations

Relation between platelet indices and branch retinal vein occlusion in hypertensive patients

Halil Ibrahim Onder et al. Indian J Ophthalmol. 2013 Apr.

Abstract

Background: Branch retinal vein occlusion (BRVO) is the second most common retinal vascular disease after diabetic retinopathy. To date, the studies were unable to elucidate the mechanism of the thrombosis leading to the entity; particularly the relation between thrombocyte aggregation and retinal vein occlusion is still unclear. Mean platelet volume (MPV) is a determinant of rate of platelet production and activation, both of which are indices of function of platelets. The relation between MPV and BRVO has not been studied before. The aim was to evaluate MPV in BRVO.

Materials and methods: Forty patients were included in the study. Forty six age and sex matched hypertensive volunteers were recruited as the control group.

Results: MPV values were significantly higher in BRVO patients compared with the control subjects (8.01 ± 0.79 vs 7.52 ± 0.32 fL, respectively; P < 0.001).

Conclusion: MPV is significantly higher in patients hypertensive BRVO patients and further investigations regarding its potentially use as a prognostic biomarker in patients with BRVO are needed.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No.

Comment in

References

    1. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, et al. International Eye Disease Consortium. The prevalence of retinal vein occlusion: Pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117:313–9. - PMC - PubMed
    1. Wong TY, Scott IU. Clinical practice. Retinal-vein occlusion. N Engl J Med. 2010;363:2135–44. - PubMed
    1. Turello M, Pasca S, Daminato R, Dello Russo P, Giacomello R, Venturelli U, et al. Retinal vein occlusion: Evaluation of ‘classic’ and ‘emerging’ risk factors and treatment. J Thromb Thrombolysis. 2010;29:459–64. - PubMed
    1. Wong TY, Larsen EK, Klein R, Mitchell P, Couper DJ, Klein BE, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: The Atherosclerosis Risk in Communities and Cardiovascular Health Studies. Ophthalmology. 2005;112:540–7. - PubMed
    1. Cheung N, Klein R, Wang JJ, Cotch MF, Islam AF, Klein BE, et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: The Multiethnic Study of Atherosclerosis. Invest Ophthalmol Vis Sci. 2008;49:4297–302. - PMC - PubMed